Description
SCH-900776 is an inhibitor of checkpoint kinase 1 (Chk1) that exhibits anticancer chemotherapeutic activity. SCH-900776 is currently in clinical trials as a potential co-administered treatment for cancer. With other chemotherapeutics, SCH-900776 induces double-stranded DNA strand breaks and cell death.